Skin regeneration using dermal substrates that contain autologous cells and silver nanoparticles to promote antibacterial activity: In vitro studies

Michael A J Zieger, Manuel Ochoa, Rahim Rahimi, Gonzalo Campana, Sunil Tholpady, Babak Ziaie, Rajiv Sood

Research output: Contribution to journalArticle

Abstract

We hypothesized that the addition of silver nanoparticles (AgNP) to a dermal substrate would impart antibacterial properties without inhibiting the proliferation of contained cells. Our in vitro model was based on the commercial substrate, Integra. The substrate was prepared by simple immersion into 0 to 1% suspension of AgNP (75 or 200 nm diameter) followed by rinsing for 20 minutes and sterilization under an ultraviolet C lamp. A total of 107 human adipose stem cells per cubic centimeter were injected and after 1 hour, 6 × 105 keratinocytes/cm2 were seeded and cultured for up to 14 days. Constructs were evaluated using a metabolic assay (WST-1), and hematoxylin and eosin and immunoperoxidase staining. Bactericidal activity was measured using a log reduction assay against bacteria that are prevalent in burns. The presence of AgNP did not significantly change the metabolic activity of constructs after 14 days of culture, and the distribution of cells within the substrate was unchanged from the controls that did not have AgNP. Antibacterial activity of Integra containing AgNP (75 nm diameter) was concentration dependent. In conclusion, the addition of AgNP to the dermal substrate suppressed bacterial growth but did not significantly affect cell proliferation, and may represent an important property to incorporate into a future clinical skin regeneration system.

Original languageEnglish (US)
Article number376
Pages (from-to)376-382
Number of pages7
JournalMilitary Medicine
Volume182
DOIs
StatePublished - Mar 1 2017

Fingerprint

Silver
Nanoparticles
Regeneration
Skin
Cell Proliferation
Immersion
Hematoxylin
Eosine Yellowish-(YS)
Burns
Keratinocytes
Suspensions
Stem Cells
Cell Culture Techniques
Staining and Labeling
Bacteria
Growth
In Vitro Techniques

ASJC Scopus subject areas

  • Medicine(all)
  • Public Health, Environmental and Occupational Health

Cite this

Skin regeneration using dermal substrates that contain autologous cells and silver nanoparticles to promote antibacterial activity : In vitro studies. / Zieger, Michael A J; Ochoa, Manuel; Rahimi, Rahim; Campana, Gonzalo; Tholpady, Sunil; Ziaie, Babak; Sood, Rajiv.

In: Military Medicine, Vol. 182, 376, 01.03.2017, p. 376-382.

Research output: Contribution to journalArticle

Zieger, Michael A J ; Ochoa, Manuel ; Rahimi, Rahim ; Campana, Gonzalo ; Tholpady, Sunil ; Ziaie, Babak ; Sood, Rajiv. / Skin regeneration using dermal substrates that contain autologous cells and silver nanoparticles to promote antibacterial activity : In vitro studies. In: Military Medicine. 2017 ; Vol. 182. pp. 376-382.
@article{37d135f2fcd6466ea67c43f92577d155,
title = "Skin regeneration using dermal substrates that contain autologous cells and silver nanoparticles to promote antibacterial activity: In vitro studies",
abstract = "We hypothesized that the addition of silver nanoparticles (AgNP) to a dermal substrate would impart antibacterial properties without inhibiting the proliferation of contained cells. Our in vitro model was based on the commercial substrate, Integra. The substrate was prepared by simple immersion into 0 to 1{\%} suspension of AgNP (75 or 200 nm diameter) followed by rinsing for 20 minutes and sterilization under an ultraviolet C lamp. A total of 107 human adipose stem cells per cubic centimeter were injected and after 1 hour, 6 × 105 keratinocytes/cm2 were seeded and cultured for up to 14 days. Constructs were evaluated using a metabolic assay (WST-1), and hematoxylin and eosin and immunoperoxidase staining. Bactericidal activity was measured using a log reduction assay against bacteria that are prevalent in burns. The presence of AgNP did not significantly change the metabolic activity of constructs after 14 days of culture, and the distribution of cells within the substrate was unchanged from the controls that did not have AgNP. Antibacterial activity of Integra containing AgNP (75 nm diameter) was concentration dependent. In conclusion, the addition of AgNP to the dermal substrate suppressed bacterial growth but did not significantly affect cell proliferation, and may represent an important property to incorporate into a future clinical skin regeneration system.",
author = "Zieger, {Michael A J} and Manuel Ochoa and Rahim Rahimi and Gonzalo Campana and Sunil Tholpady and Babak Ziaie and Rajiv Sood",
year = "2017",
month = "3",
day = "1",
doi = "10.7205/MILMED-D-16-00133",
language = "English (US)",
volume = "182",
pages = "376--382",
journal = "Military Medicine",
issn = "0026-4075",
publisher = "Association of Military Surgeons of the US",

}

TY - JOUR

T1 - Skin regeneration using dermal substrates that contain autologous cells and silver nanoparticles to promote antibacterial activity

T2 - In vitro studies

AU - Zieger, Michael A J

AU - Ochoa, Manuel

AU - Rahimi, Rahim

AU - Campana, Gonzalo

AU - Tholpady, Sunil

AU - Ziaie, Babak

AU - Sood, Rajiv

PY - 2017/3/1

Y1 - 2017/3/1

N2 - We hypothesized that the addition of silver nanoparticles (AgNP) to a dermal substrate would impart antibacterial properties without inhibiting the proliferation of contained cells. Our in vitro model was based on the commercial substrate, Integra. The substrate was prepared by simple immersion into 0 to 1% suspension of AgNP (75 or 200 nm diameter) followed by rinsing for 20 minutes and sterilization under an ultraviolet C lamp. A total of 107 human adipose stem cells per cubic centimeter were injected and after 1 hour, 6 × 105 keratinocytes/cm2 were seeded and cultured for up to 14 days. Constructs were evaluated using a metabolic assay (WST-1), and hematoxylin and eosin and immunoperoxidase staining. Bactericidal activity was measured using a log reduction assay against bacteria that are prevalent in burns. The presence of AgNP did not significantly change the metabolic activity of constructs after 14 days of culture, and the distribution of cells within the substrate was unchanged from the controls that did not have AgNP. Antibacterial activity of Integra containing AgNP (75 nm diameter) was concentration dependent. In conclusion, the addition of AgNP to the dermal substrate suppressed bacterial growth but did not significantly affect cell proliferation, and may represent an important property to incorporate into a future clinical skin regeneration system.

AB - We hypothesized that the addition of silver nanoparticles (AgNP) to a dermal substrate would impart antibacterial properties without inhibiting the proliferation of contained cells. Our in vitro model was based on the commercial substrate, Integra. The substrate was prepared by simple immersion into 0 to 1% suspension of AgNP (75 or 200 nm diameter) followed by rinsing for 20 minutes and sterilization under an ultraviolet C lamp. A total of 107 human adipose stem cells per cubic centimeter were injected and after 1 hour, 6 × 105 keratinocytes/cm2 were seeded and cultured for up to 14 days. Constructs were evaluated using a metabolic assay (WST-1), and hematoxylin and eosin and immunoperoxidase staining. Bactericidal activity was measured using a log reduction assay against bacteria that are prevalent in burns. The presence of AgNP did not significantly change the metabolic activity of constructs after 14 days of culture, and the distribution of cells within the substrate was unchanged from the controls that did not have AgNP. Antibacterial activity of Integra containing AgNP (75 nm diameter) was concentration dependent. In conclusion, the addition of AgNP to the dermal substrate suppressed bacterial growth but did not significantly affect cell proliferation, and may represent an important property to incorporate into a future clinical skin regeneration system.

UR - http://www.scopus.com/inward/record.url?scp=85015189957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015189957&partnerID=8YFLogxK

U2 - 10.7205/MILMED-D-16-00133

DO - 10.7205/MILMED-D-16-00133

M3 - Article

C2 - 28291502

AN - SCOPUS:85015189957

VL - 182

SP - 376

EP - 382

JO - Military Medicine

JF - Military Medicine

SN - 0026-4075

M1 - 376

ER -